Report Materials
For the fiscal year (FY) 2022 coordinated oversight plan, the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) plans to conduct PEPFAR program integrity and fraud prevention activities. The Centers for Disease Control and Prevention (CDC) received over $5.5 billion for FYs 2018 through 2020 (about 96 percent of the funds received by HHS during the three FYs) to accelerate HIV treatment and prevention worldwide by using public health, innovation, and data-driven approaches to achieve the global goal of HIV epidemic control.
The CDC has been working to combat HIV since the start of the HIV epidemic. As an implementing agency of PEPFAR, the CDC works side by side with ministries of health and other partners, leveraging its scientific and technical expertise to help deliver high-impact, sustainable HIV treatment and prevention services to millions of people in the countries most affected by HIV. To date, HHS-OIG has conducted 30 PEPFAR audits of the CDC or recipients in 9 countries on 3 continents (Africa, Asia, and North America). HHS-OIG's PEPFAR oversight has helped the CDC, HHS staff, and grant recipients to learn important grant and program integrity lessons that apply to ongoing and future responses to infectious diseases.
For FY 2022, HHS-OIG has four ongoing audits to complete, two planned audits to start (one domestic and one international [in-country]), and fraud prevention training to conduct.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.